A multi-center, randomized, open, treatment-switching study from orally administered antipsychotic monotherapy in the treatment of chronic schizophrenic and schizoaffective patients

Trial Profile

A multi-center, randomized, open, treatment-switching study from orally administered antipsychotic monotherapy in the treatment of chronic schizophrenic and schizoaffective patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Aripiprazole (Primary) ; Antipsychotics
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Acronyms SWAT
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 15 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Dec 2009 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
    • 01 Jul 2009 Results have been published in the International Clinical Psychopharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top